机构

• 上海药物研究所 [600]

采集方式

• OAI收割 [600]

内容类型

• 期刊论文 [590]
• 会议论文 [10]

发表日期

• 2024 [9]
• 2023 [47]
• 2022 [53]
• 2021 [63]
• 2020 [40]
• 2019 [42]
• 更多

学科主题

• Biochemist... [2]
• Cell Biolo... [1]
• Chemistry [1]
• Oncology [1]
• Pharmacolo... [1]

筛选

浏览/检索结果: 共600条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma 期刊论文  OAI收割 CLINICAL PROTEOMICS, 2024, 卷号: 21, 期号: 1, 页码: 11 作者:  Huang, Yuqi;  Ma, Sheng;  Xu, Jun-Yu;  Qian, Kun;  Wang, Yaru   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/02/19 Lung adenocarcinoma  Proteome  Benign lung disease cases  Solid pathological subtype  Prognostic biomarker   In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes 期刊论文  OAI收割 JOURNAL OF ETHNOPHARMACOLOGY, 2024, 卷号: 322, 页码: 10 作者:  Liu, Suyan;  Zhao, Yong;  Tang, Xuan;  Yang, Junling;  Pan, Chen   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/02/27 Sesquiterpenoids  Inhibition  CYP450s  Drug-drug interactions  Mechanism   Ent-labdane-type diterpene glycosides obtained from Rubus chingii Hu and their inhibitory effects on PDE5A activity 期刊论文  OAI收割 FITOTERAPIA, 2024, 卷号: 173, 页码: 14 作者:  Yu, Jun-dong;  Wang, Jing-Yi;  Liu, Jia-yuan;  Xu, Ye-chun;  Zhang, Xue   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/02/27 diterpene glycosides  Rubus Chingii Hu  PDE5A inhibitory activity  ent-labdane   PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 12 作者:  Zhang, Shunan;  Lai, Yi;  Pan, Jiaxing;  Saeed, Madiha;  Li, Shiqin   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/09 active tumor targeting  nanosensitizer  PROTAC prodrug  radiation therapy  tumor microenvironment   Patchouli Alcohol: A Natural Sesquiterpene Against Both Inflammation and Intestinal Barrier Damage of Ulcerative Colitis (vol 43, pg 1423, 2020) 期刊论文  OAI收割 INFLAMMATION, 2024, 页码: 2 作者:  Wu, Zhuona;  Zeng, Hairong;  Zhang, Lili;  Pu, Yiqiong;  Li, Suyun   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/04/09 A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy 期刊论文  OAI收割 CANCER COMMUNICATIONS, 2024, 页码: 5 作者:  Liu, Yingqiang;  Tong, Linjiang;  Zhang, Mengge;  Zhang, Qi;  Liu, Qiupei   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/03/13 Discovery of a 1,6-naphthyridin-4-one-based AXL inhibitor with improved pharmacokinetics and enhanced in vivo antitumor efficacy 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 17 作者:  Lan, Yaohan;  Peng, Xia;  Ji, Yinchun;  Su, Yi;  Duan, Wenhu   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/02/27 AXL inhibitor  In vivo antitumor efficacy  6-Naphthyridin-4-one derivatives  Scaffold hopping  Structure-based drug design   Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes 期刊论文  OAI收割 JOURNAL OF CONTROLLED RELEASE, 2024, 卷号: 366, 页码: 328-341 作者:  Zhu, Jie;  Wang, Rui;  Yang, Chenxiao;  Shao, Xinyue;  Zhang, Yi   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/03/06 Platelet  Circulating tumor cells (CTCs)  Glycolysis  Metastasis  Hybrid-membrane liposome  Quercetin  Shikonin   Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 16 作者:  Cheng, Chen;  Ren, Chao;  Li, Mu-zi;  Liu, Yi-hui;  Yao, Ren-qi   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/02/27 Traditional Chinese medicine  XueBiJing  sepsis  mortality  pharmacokinetic compatibility  polypharmacology   Drug repurposing and structure-based discovery of new PDE4 and PDE5 inhibitors 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 262, 页码: 14 作者:  Liu, Jiayuan;  Zhang, Xianglei;  Chen, Guofeng;  Shao, Qiang;  Zou, Yi   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/01/16 Phosphodiesterase-4 (PDE4)  PDE5  Inhibitor  Drug repurposing  Crystal structure  Structure -guided optimization